Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block with Dexmedetomidine for Hip Surgery
NCT07149168Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in femoral neck fracture (2 arms), sponsored by Ain Shams University. Primary endpoint: The success rate of achieving adequate spinal anesthesia at 24 hours. Started Dec 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
femoral neck fracture
Beyond the preview
Go deeper on NCT07149168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07149168.